CI

At a glance

ClinicalIndex Comparison Record
N/AEnrolling by Invitation· 60 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07011875
NCT07011875N/AEnrolling by InvitationUpdate OverdueUpdated 12mo ago · Completion was 11mo ago
Enrollment Stalled

The Effect of Physical Activity Levels on Dysmenorrhea Severity, Menstrual Symptoms, and Functional and Emotional Status in Women Diagnosed With Multiple Sclerosis

Karabuk University·observational·Posted Jun 10, 2025·Updated Jun 10, 2025

In Brief

An observational study for Multiple Sclerosis and 3 related conditions. Currently enrolling by invitation, targeting 60 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease that affects the central nervous system. It is more common in women, and hormonal factors are believed to play a role in its progression. The relapsing-remitting form of MS is particularly prevalent among women, leading to fluctuations in symptoms throughout the menstrual cycle. One of the symptoms experienced during menstruation is dysmenorrhea, which can significantly impact quality of life due to severe pain and functional limitations. Dysmenorrhea is associated with both emotional and physical symptoms, and in women with MS, neurological symptoms may further intensify menstrual discomfort. Physical activity is known to reduce inflammation and improve overall health. It has been shown to positively affect both MS symptoms and menstrual symptoms, including dysmenorrhea. However, research specifically examining the effects of physical activity on dysmenorrhea severity, menstrual symptoms, and emotional well-being in women with MS is limited. This study aims to evaluate the impact of physical activity levels on dysmenorrhea severity, menstrual symptoms, and emotional well-being in women diagnosed with MS, addressing a gap in the literature and contributing to clinical practice.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/AEnrolling by InvitationOverdue
2026
First PostedJun 10, 2025
Enrollment StartJun 2, 2025
Primary CompletionAug 1, 2025
Study CompletionSep 1, 2025
TodayJul 1, 2026
Enrollment to primary: 2 monthsPosted 1.1 years ago